Characterization of Women’s Health Benefit Claims Made on Cannabis E-Commerce Platforms: A Retrospective Market Surveillance Study

IF 4.7 2区医学 Q1 MEDICINE, GENERAL & INTERNAL

American Journal of Preventive Medicine Pub Date : 2026-04-01 Epub Date: 2025-11-07 DOI:10.1016/j.amepre.2025.108183

Matthew C. Nali BA , Meng Zhen Larsen BA, BS , Zhuoran Li MS , Jiawei Li MS , Cassandra L. Taylor PhD , Geoffrey A. Dubrow PhD , Beverly J. Wolpert PhD, MS , Catharine Trice MA , Tim K. Mackey MAS, PhD

{"title":"Characterization of Women’s Health Benefit Claims Made on Cannabis E-Commerce Platforms: A Retrospective Market Surveillance Study","authors":"Matthew C. Nali BA , Meng Zhen Larsen BA, BS , Zhuoran Li MS , Jiawei Li MS , Cassandra L. Taylor PhD , Geoffrey A. Dubrow PhD , Beverly J. Wolpert PhD, MS , Catharine Trice MA , Tim K. Mackey MAS, PhD","doi":"10.1016/j.amepre.2025.108183","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Consumer interest in cannabis-derived products remains high, including among women, a growing demographic group. This study examined women’s reproductive health claims in cannabis-derived product e-commerce listings to better understand their potential consumer risk.</div></div><div><h3>Methods</h3><div>This study involved 3 phases: (1) data mining U.S. product listings from cannabis e-commerce websites Leafly and Weedmaps; (2) keyword filtering related to women’s health and reproductive topics; and (3) content coding of cannabis-derived product listings for women’s health benefits, including product characteristics, such as route of administration, and any accompanying health warnings and user-generated reviews all conducted in September–November 2023.</div></div><div><h3>Results</h3><div>A total of 1,463,510 unique cannabis-derived product listings were collected from Leafly and Weedmaps. After keyword filtering and content coding, 408 listings mapped to 465 health benefit claims across 5 major women’s health areas: menstrual cycle (57.2%, <em>n</em>=266), fertility (14.0%, <em>n</em>=65), women’s health conditions (13.1%, <em>n</em>=61), menopausal transition (15.0%, <em>n</em>=70), and maternal health (0.7%, <em>n</em>=3). Among these 408 cannabis-derived product listings, only 6.6% (<em>n</em>=27) contained disclaimers with health warning language. For products making women’s health claims, the top product route of administration was topical/transdermal application (e.g., dermatological agents, transdermal products, <em>n</em>=135). Product reviews contained 14 comments with thematic relevance to stated health benefit claim(s), including with 12 (85.7%) positive and 2 (14.3%) negative.</div></div><div><h3>Conclusions</h3><div>This study found >400 unique cannabis-derived products promoting various women-focused health benefits on 2 cannabis e-commerce sites, despite known reproductive and maternal health risks. Additional research is needed to understand how women perceive these marketed benefits and how they influence product use and behavior.</div></div>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":"70 4","pages":"Article 108183"},"PeriodicalIF":4.7000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Preventive Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0749379725006518","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/11/7 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction

Consumer interest in cannabis-derived products remains high, including among women, a growing demographic group. This study examined women’s reproductive health claims in cannabis-derived product e-commerce listings to better understand their potential consumer risk.

Methods

This study involved 3 phases: (1) data mining U.S. product listings from cannabis e-commerce websites Leafly and Weedmaps; (2) keyword filtering related to women’s health and reproductive topics; and (3) content coding of cannabis-derived product listings for women’s health benefits, including product characteristics, such as route of administration, and any accompanying health warnings and user-generated reviews all conducted in September–November 2023.

Results

A total of 1,463,510 unique cannabis-derived product listings were collected from Leafly and Weedmaps. After keyword filtering and content coding, 408 listings mapped to 465 health benefit claims across 5 major women’s health areas: menstrual cycle (57.2%, n=266), fertility (14.0%, n=65), women’s health conditions (13.1%, n=61), menopausal transition (15.0%, n=70), and maternal health (0.7%, n=3). Among these 408 cannabis-derived product listings, only 6.6% (n=27) contained disclaimers with health warning language. For products making women’s health claims, the top product route of administration was topical/transdermal application (e.g., dermatological agents, transdermal products, n=135). Product reviews contained 14 comments with thematic relevance to stated health benefit claim(s), including with 12 (85.7%) positive and 2 (14.3%) negative.

Conclusions

This study found >400 unique cannabis-derived products promoting various women-focused health benefits on 2 cannabis e-commerce sites, despite known reproductive and maternal health risks. Additional research is needed to understand how women perceive these marketed benefits and how they influence product use and behavior.

查看原文本刊更多论文

大麻电子商务平台上女性健康益处声明的特征：回顾性市场监测研究

导言：消费者对大麻衍生产品（cdp）的兴趣仍然很高，包括妇女，这是一个不断增长的人口群体。本研究调查了女性在CDP电子商务列表中的生殖健康声明，以更好地了解其潜在的消费者风险。方法：本研究分为三个阶段：(1)对大麻电子商务网站Leafly和Weedmaps的美国产品清单进行数据挖掘；(2)与妇女健康和生殖主题相关的关键词过滤；(3)关于妇女健康益处的CDP清单的内容编码，包括产品特征，如给药途径（RoA），以及任何附带的健康警告和用户生成的评论，所有这些都是在2023年9月至11月进行的。结果：在Leafly和Weedmaps上共收集到1463510个独特的CDP列表。经过关键词过滤和内容编码，408个清单映射到465个健康福利索赔，涉及五个主要的女性健康领域：月经周期（57.2%,n=266）、生育（14.0%,n=65）、女性健康状况（13.1%,n=61）、更年期过渡（15.0%,n=70）和孕产妇健康（0.7%,n=3）。在这408个CDP列表中，只有6.6% （n=27）包含带有健康警告语言的免责声明。对于声称妇女健康的产品，最大的产品RoA是外用/透皮应用（例如，皮肤病制剂，透皮产品，n=135）。产品评论包含14条与所述健康益处声明主题相关的评论，包括12条（85.7%）正面评论和2条（14.3%）负面评论。结论：本研究发现，尽管存在已知的生殖和孕产妇健康风险，但在两个大麻电子商务网站上，仍有400个独特的cdp促进了各种以女性为重点的健康益处。需要进一步的研究来了解妇女如何看待这些市场上的好处，以及它们如何影响产品的使用和行为。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American Journal of Preventive Medicine 医学-公共卫生、环境卫生与职业卫生

CiteScore

8.60

自引率

1.80%

发文量

395

审稿时长

32 days

期刊介绍： The American Journal of Preventive Medicine is the official journal of the American College of Preventive Medicine and the Association for Prevention Teaching and Research. It publishes articles in the areas of prevention research, teaching, practice and policy. Original research is published on interventions aimed at the prevention of chronic and acute disease and the promotion of individual and community health. Of particular emphasis are papers that address the primary and secondary prevention of important clinical, behavioral and public health issues such as injury and violence, infectious disease, women''s health, smoking, sedentary behaviors and physical activity, nutrition, diabetes, obesity, and substance use disorders. Papers also address educational initiatives aimed at improving the ability of health professionals to provide effective clinical prevention and public health services. Papers on health services research pertinent to prevention and public health are also published. The journal also publishes official policy statements from the two co-sponsoring organizations, review articles, media reviews, and editorials. Finally, the journal periodically publishes supplements and special theme issues devoted to areas of current interest to the prevention community.